Company intelligence / Profile preview
Intragrand Pharma
Hangzhou, Zhejiang, China
- Ownership
- Private
- Employees
- ~60
- Development stage
- Other
01
Overview
Intragrand is a clinical-stage biopharmaceutical company focused on the discovery and development of targeted protein degradation (TPD) therapies. The company utilizes its proprietary IG-Glue platform to identify and optimize molecular glue degraders and PROTACs for previously "undruggable" protein targets. Its lead candidate, IG-001, is a potent molecular glue degrader targeting GSPT1, currently in Phase 1 clinical trials for the treatment of advanced solid tumors. Based in Hangzhou, China, Intragrand aims to address significant unmet medical needs in oncology and immunology through innovative protein degradation mechanisms.
- Therapeutic areas
- OncologyImmunology
- Modalities
- Molecular glue therapyProteolysis-targeting chimera therapySmall molecule
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Intragrand Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Intragrand Pharma.